Open for inclusion

Safety and tolerability of single and repeated doses of ODM-203: an opel-label, non-randomized, uncontrolled, dose escalation, multicentre, first-in-human study in subjects with advanced solid tumors

Cancer type: Solide tumores

Phase: I

Principal Investigator: Bono Petri

Country: FI

Keywords: Finland, Helsinki, phase 1, solid tumors

Status: Open for inclusion

Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02264418